Westlake Chemical Partners LP
NYSE:WLKP
22.99 (USD) • At close November 11, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,190.791 | 1,593.147 | 1,214.858 | 966.67 | 1,091.871 | 1,285.622 | 1,172.981 | 986.736 | 1,007.221 | 1,749.7 | 2,127.747 | 2,249.098 | 2,251.043 |
| Cost of Revenue
| 803.332 | 1,215.782 | 773.152 | 587.787 | 712.443 | 908.463 | 769.314 | 595.405 | 624.339 | 1,003.888 | 1,255.14 | 1,613.446 | 1,841.945 |
| Gross Profit
| 387.459 | 377.365 | 441.706 | 378.883 | 379.428 | 377.159 | 403.667 | 391.331 | 382.882 | 745.812 | 872.607 | 635.652 | 409.098 |
| Gross Profit Ratio
| 0.325 | 0.237 | 0.364 | 0.392 | 0.348 | 0.293 | 0.344 | 0.397 | 0.38 | 0.426 | 0.41 | 0.283 | 0.182 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 27.085 | 26.621 | 28.577 | 22.162 | 26.946 | 24.618 | 27.262 | 21.971 | 20.681 | 21.302 | 24.054 | 22.485 | 0 |
| Selling & Marketing Expenses
| 2.666 | 3.057 | 2.441 | 3.733 | 2.332 | 2.972 | 1.998 | 2.916 | 2.869 | 7.954 | 1.397 | 1.618 | 0 |
| SG&A
| 29.751 | 29.678 | 31.018 | 25.895 | 29.278 | 27.59 | 29.26 | 24.887 | 23.55 | 29.256 | 25.451 | 24.103 | 24.312 |
| Other Expenses
| 4.232 | 1.566 | 0.062 | 0.733 | 3.096 | 2.457 | 1.792 | 0.601 | 0.16 | 3.151 | 7.701 | 4.186 | 2.804 |
| Operating Expenses
| 29.751 | 29.678 | 31.018 | 25.895 | 29.278 | 27.59 | 29.26 | 24.887 | 23.55 | 29.256 | 25.451 | 24.103 | 24.312 |
| Operating Income
| 357.708 | 347.687 | 410.688 | 352.988 | 350.15 | 349.569 | 374.407 | 366.444 | 359.332 | 716.556 | 847.156 | 611.549 | 384.786 |
| Operating Income Ratio
| 0.3 | 0.218 | 0.338 | 0.365 | 0.321 | 0.272 | 0.319 | 0.371 | 0.357 | 0.41 | 0.398 | 0.272 | 0.171 |
| Total Other Income Expenses Net
| -22.269 | -11.841 | -8.754 | -11.305 | -16.527 | -18.976 | -20.069 | -12.006 | -4.807 | -7.348 | -0.331 | -4.751 | -6.143 |
| Income Before Tax
| 335.439 | 335.846 | 401.934 | 341.683 | 333.623 | 330.593 | 354.338 | 354.438 | 354.525 | 709.208 | 846.825 | 606.798 | 378.643 |
| Income Before Tax Ratio
| 0.282 | 0.211 | 0.331 | 0.353 | 0.306 | 0.257 | 0.302 | 0.359 | 0.352 | 0.405 | 0.398 | 0.27 | 0.168 |
| Income Tax Expense
| 0.813 | 1.017 | 0.549 | 0.564 | 0.728 | 0.022 | 1.28 | 1.035 | 0.672 | 199.388 | 300.279 | 210.878 | 131.67 |
| Net Income
| 54.283 | 334.829 | 401.385 | 341.119 | 332.895 | 49.347 | 48.67 | 40.94 | 39.831 | 13.577 | 546.546 | 395.92 | 246.973 |
| Net Income Ratio
| 0.046 | 0.21 | 0.33 | 0.353 | 0.305 | 0.038 | 0.041 | 0.041 | 0.04 | 0.008 | 0.257 | 0.176 | 0.11 |
| EPS
| 1.54 | 9.51 | 11.4 | 9.69 | 9.65 | 1.53 | 1.72 | 1.5 | 1.47 | 0.5 | 21.54 | 15.6 | 9.73 |
| EPS Diluted
| 1.54 | 9.51 | 11.4 | 9.69 | 9.65 | 1.51 | 1.72 | 1.5 | 1.47 | 0.5 | 21.54 | 15.6 | 9.73 |
| EBITDA
| 472.143 | 470.327 | 519.564 | 456.875 | 460.566 | 460.868 | 490.184 | 464.919 | 440.507 | 797.318 | 928.32 | 679.992 | 444.783 |
| EBITDA Ratio
| 0.393 | 0.295 | 0.428 | 0.473 | 0.422 | 0.358 | 0.418 | 0.472 | 0.438 | 0.456 | 0.436 | 0.302 | 0.198 |